MENU
KROS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Keros Therapeutics (KROS) Ownership - Who owns Keros Therapeutics?
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs... Show more
Profile
Industry
N/A
Address
1050 Waltham Street
Phone
+1 617 314-6297
Employees
136
Web
https://www.kerostx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
633.19M
P/E Ratio
48.72
Total Cash
690.22M
Projected Growth
N/A
Total Debt
17.95M
Revenue
232.84M
Risk (Beta)
1.11
Dividend Yield
N/A
Total Cash/Share
16.99
Total Debt/Equity
N/A
Revenue/Share
5.81 USD as % of share price
Fundamentals
KROS
Capitalization
633M
P/E Ratio
48.72
Risk (Beta)
1.11
Dividend Yield
N/A
Total Cash
690M
Total Cash/Share
16.99
Total Debt
18M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
5.81%
Revenue
233M
ROE
N/A
Book Value
707M
P/B Ratio
0.90
Cash Flow
N/A
Earnings
0.36
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
21.11
Current Revenue Per Employee
122756.76
Dividends Per Share - Security
N/A
EBITDA
25.5M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
3.10
Shares Held By Institutions
644M
Shares Outstanding - Current
40.6M
Total Liabilities
50.4M
Total Volume MTD
N/A
Value
-1
Gain YTD
-1.516
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. KROS showed earnings on August 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a biopharmaceutical company, which focuses on treatments for rare muscle diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1050 Waltham Street
Phone
+1 617 314-6297
Employees
136
Web
https://www.kerostx.com